Mirati Therapeutics, Inc.·4

Jun 3, 5:56 PM ET

Stelzer Laurie 4

4 · Mirati Therapeutics, Inc. · Filed Jun 3, 2022

Insider Transaction Report

Form 4
Period: 2022-06-01
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-06-01+91,16491,164 total
    Exercise: $39.93Exp: 2032-05-31Common Stock (91,164 underlying)
  • Award

    Common Stock

    2022-06-01+57,79857,798 total
Footnotes (2)
  • [F1]This represents a Restricted Stock Unit grant with a vesting period of 4 years that vests 25% annually from grant date.
  • [F2]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.

Documents

1 file
  • 4
    marketforms-56337.xmlPrimary

    PRIMARY DOCUMENT